

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.65910236 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.60246890 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.60246890 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.60219129 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.07620704 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.07620704 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 5.97158582 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.94703368 |
| 9 | positive thymic T cell selection (GO:0045059) | 5.91599413 |
| 10 | B cell receptor signaling pathway (GO:0050853) | 5.59393888 |
| 11 | negative T cell selection (GO:0043383) | 5.49273494 |
| 12 | negative thymic T cell selection (GO:0045060) | 5.42816104 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.35524654 |
| 14 | positive T cell selection (GO:0043368) | 5.24222852 |
| 15 | thymic T cell selection (GO:0045061) | 5.15023286 |
| 16 | response to interleukin-15 (GO:0070672) | 5.13399005 |
| 17 | T cell selection (GO:0045058) | 5.11523450 |
| 18 | regulation of regulatory T cell differentiation (GO:0045589) | 4.89483851 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75855221 |
| 20 | regulation of B cell differentiation (GO:0045577) | 4.52776379 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.45155759 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 4.42680834 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 4.40309825 |
| 24 | leukocyte aggregation (GO:0070486) | 4.35888008 |
| 25 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.30600305 |
| 26 | tolerance induction (GO:0002507) | 4.23234443 |
| 27 | positive regulation of Rap GTPase activity (GO:0032854) | 4.11853131 |
| 28 | T cell migration (GO:0072678) | 4.09590445 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 4.08843322 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 4.08843322 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.08843322 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.08843322 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.08843322 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 4.08843322 |
| 35 | T cell receptor signaling pathway (GO:0050852) | 4.06407691 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 3.92744288 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.88680900 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.86002887 |
| 39 | positive regulation of histone deacetylation (GO:0031065) | 3.82756738 |
| 40 | T cell costimulation (GO:0031295) | 3.79776861 |
| 41 | T cell homeostasis (GO:0043029) | 3.79604694 |
| 42 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.75674476 |
| 43 | lymphocyte costimulation (GO:0031294) | 3.72547851 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.63405893 |
| 45 | neutrophil activation (GO:0042119) | 3.60715779 |
| 46 | positive regulation of tolerance induction (GO:0002645) | 3.60261571 |
| 47 | interferon-gamma production (GO:0032609) | 3.56533338 |
| 48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.54265376 |
| 49 | positive regulation of interleukin-2 production (GO:0032743) | 3.53537861 |
| 50 | detection of bacterium (GO:0016045) | 3.45090639 |
| 51 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.43611657 |
| 52 | histone H3-K4 trimethylation (GO:0080182) | 3.41690299 |
| 53 | regulation of Rap GTPase activity (GO:0032317) | 3.41485430 |
| 54 | detection of other organism (GO:0098543) | 3.41332617 |
| 55 | mast cell degranulation (GO:0043303) | 3.41102826 |
| 56 | mast cell activation involved in immune response (GO:0002279) | 3.41102826 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 3.40649661 |
| 58 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40058734 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.39364591 |
| 60 | natural killer cell differentiation (GO:0001779) | 3.39170709 |
| 61 | germinal center formation (GO:0002467) | 3.37662083 |
| 62 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.37660110 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.37209300 |
| 64 | lymphocyte homeostasis (GO:0002260) | 3.33861094 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.32935954 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 3.30957648 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.28139849 |
| 68 | leukocyte degranulation (GO:0043299) | 3.26646697 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 3.24406594 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.21816039 |
| 71 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.21816039 |
| 72 | myeloid cell activation involved in immune response (GO:0002275) | 3.21355746 |
| 73 | mast cell activation (GO:0045576) | 3.21335415 |
| 74 | activated T cell proliferation (GO:0050798) | 3.20933294 |
| 75 | B cell proliferation (GO:0042100) | 3.18736470 |
| 76 | granulocyte activation (GO:0036230) | 3.17901192 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 3.15887718 |
| 78 | mature B cell differentiation (GO:0002335) | 3.13063220 |
| 79 | defense response to protozoan (GO:0042832) | 3.12862303 |
| 80 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.12739023 |
| 81 | response to peptidoglycan (GO:0032494) | 3.12627874 |
| 82 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11727082 |
| 83 | adaptation of signaling pathway (GO:0023058) | 3.11517843 |
| 84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.10145754 |
| 85 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.08796558 |
| 86 | Peyers patch development (GO:0048541) | 3.08796558 |
| 87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.08348088 |
| 88 | regulation of mast cell activation (GO:0033003) | 3.07885454 |
| 89 | regulation of tolerance induction (GO:0002643) | 3.06620823 |
| 90 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.04255773 |
| 91 | negative regulation of interleukin-12 production (GO:0032695) | 3.02196555 |
| 92 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.01590385 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.01508299 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 2.99302806 |
| 95 | leukocyte homeostasis (GO:0001776) | 2.96598163 |
| 96 | megakaryocyte development (GO:0035855) | 2.93498566 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 2.88424138 |
| 98 | response to type I interferon (GO:0034340) | 2.88253112 |
| 99 | B cell homeostasis (GO:0001782) | 2.87776887 |
| 100 | response to protozoan (GO:0001562) | 2.87406197 |
| 101 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.85865000 |
| 102 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.85865000 |
| 103 | leukocyte cell-cell adhesion (GO:0007159) | 2.84863951 |
| 104 | cellular response to type I interferon (GO:0071357) | 2.84296218 |
| 105 | type I interferon signaling pathway (GO:0060337) | 2.84296218 |
| 106 | regulation of interleukin-2 production (GO:0032663) | 2.83624881 |
| 107 | cellular extravasation (GO:0045123) | 2.83288979 |
| 108 | lymph node development (GO:0048535) | 2.82345396 |
| 109 | positive regulation of protein deacetylation (GO:0090312) | 2.81905589 |
| 110 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81693694 |
| 111 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81584958 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 2.81446777 |
| 113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80904055 |
| 114 | histone H3-K4 methylation (GO:0051568) | 2.80600881 |
| 115 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79214149 |
| 116 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.79066236 |
| 117 | response to host immune response (GO:0052572) | 2.79066236 |
| 118 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78665265 |
| 119 | V(D)J recombination (GO:0033151) | 2.78151285 |
| 120 | regulation of ARF protein signal transduction (GO:0032012) | 2.77600246 |
| 121 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.77137239 |
| 122 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.76449383 |
| 123 | negative regulation of innate immune response (GO:0045824) | 2.75785184 |
| 124 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.75410953 |
| 125 | negative regulation of type I interferon production (GO:0032480) | 2.74464672 |
| 126 | cellular response to zinc ion (GO:0071294) | 2.73025308 |
| 127 | interkinetic nuclear migration (GO:0022027) | 2.72164648 |
| 128 | regulation of granulocyte differentiation (GO:0030852) | 2.71196575 |
| 129 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.71142078 |
| 130 | mononuclear cell proliferation (GO:0032943) | 2.67559640 |
| 131 | positive regulation of isotype switching (GO:0045830) | 2.66941652 |
| 132 | T cell proliferation (GO:0042098) | 2.66629703 |
| 133 | regulation of B cell proliferation (GO:0030888) | 2.65235397 |
| 134 | negative regulation of bone resorption (GO:0045779) | 2.65166895 |
| 135 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.65063374 |
| 136 | positive regulation of immunoglobulin production (GO:0002639) | 2.65014288 |
| 137 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.64775865 |
| 138 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.63707920 |
| 139 | lymphocyte proliferation (GO:0046651) | 2.63130375 |
| 140 | positive regulation of T cell differentiation (GO:0045582) | 2.63073490 |
| 141 | natural killer cell activation (GO:0030101) | 2.62721209 |
| 142 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.62037067 |
| 143 | regulation of alpha-beta T cell activation (GO:0046634) | 2.61442699 |
| 144 | negative regulation of histone methylation (GO:0031061) | 2.60958684 |
| 145 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.60081493 |
| 146 | regulation of histone H3-K27 methylation (GO:0061085) | 2.59142774 |
| 147 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.57382800 |
| 148 | regulation of isotype switching (GO:0045191) | 2.56872840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.36059201 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.14929379 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.59371773 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.13594849 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.62440472 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.52830054 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.38930126 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.36852030 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.04982031 |
| 10 | MAF_26560356_Chip-Seq_TH1_Human | 2.98952175 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.91052616 |
| 12 | UTX_26944678_Chip-Seq_JUKART_Human | 2.87026308 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.85520397 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.81625770 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.80161106 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72252614 |
| 17 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.70689252 |
| 18 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.68248740 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.66271022 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.64622131 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62579565 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58516620 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51838409 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.37406724 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34859928 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.32803610 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30658889 |
| 28 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24739321 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18745607 |
| 30 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18725404 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15157233 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09303291 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05676495 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05464980 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05045405 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 2.00073324 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93873875 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.89008362 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88296187 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84700386 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.82666569 |
| 42 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.80302511 |
| 43 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75229159 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.68000097 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59210621 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58355993 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55860403 |
| 48 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.53270443 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50390578 |
| 50 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50324014 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47728200 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43122733 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42910570 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40831358 |
| 55 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38352469 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37313486 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30577388 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30050999 |
| 59 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29120212 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28750187 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28537218 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28448913 |
| 63 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.26448670 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24045620 |
| 65 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22453139 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22009331 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21389596 |
| 68 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19487663 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15215576 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15212148 |
| 71 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13587039 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11202466 |
| 73 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09222382 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08729349 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07220611 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06400215 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05149110 |
| 78 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05138793 |
| 79 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04429518 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03973459 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02383582 |
| 82 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02287913 |
| 83 | * P300_27268052_Chip-Seq_Bcells_Human | 1.01748381 |
| 84 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01672048 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01491864 |
| 86 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00823317 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00671835 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00507101 |
| 89 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00431970 |
| 90 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00093815 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98989759 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98823200 |
| 93 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98733906 |
| 94 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98440065 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98381355 |
| 96 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98064523 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97630846 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96763020 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96732096 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94815912 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94509975 |
| 102 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94123203 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92318942 |
| 104 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90595016 |
| 105 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90177092 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90087642 |
| 107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89511125 |
| 108 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89087746 |
| 109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.87461356 |
| 110 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87332393 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85764566 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85555027 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84943027 |
| 114 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.83405689 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83276404 |
| 116 | * P68_20966046_ChIP-Seq_HELA_Human | 0.82305978 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81780772 |
| 118 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79962538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.92355852 |
| 2 | MP0001800_abnormal_humoral_immune | 3.69355353 |
| 3 | MP0005387_immune_system_phenotype | 3.65485877 |
| 4 | MP0001790_abnormal_immune_system | 3.65485877 |
| 5 | MP0000685_abnormal_immune_system | 3.60858592 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.54766529 |
| 7 | MP0005671_abnormal_response_to | 3.25327982 |
| 8 | MP0003303_peritoneal_inflammation | 3.05798989 |
| 9 | MP0002398_abnormal_bone_marrow | 2.85882600 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.85396354 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.78497226 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.73347791 |
| 13 | MP0001819_abnormal_immune_cell | 2.72547247 |
| 14 | * MP0002723_abnormal_immune_serum | 2.70650257 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.68990224 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.66421107 |
| 17 | MP0001873_stomach_inflammation | 2.53331207 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.51058694 |
| 19 | MP0000716_abnormal_immune_system | 2.47276382 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 2.40945642 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.35073231 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.34095540 |
| 23 | MP0002722_abnormal_immune_system | 2.23414523 |
| 24 | MP0009278_abnormal_bone_marrow | 2.20790013 |
| 25 | MP0003436_decreased_susceptibility_to | 2.17734701 |
| 26 | MP0003866_abnormal_defecation | 2.11817579 |
| 27 | MP0005025_abnormal_response_to | 2.03678929 |
| 28 | MP0008961_abnormal_basal_metabolism | 2.02995376 |
| 29 | MP0002429_abnormal_blood_cell | 1.99970750 |
| 30 | MP0009785_altered_susceptibility_to | 1.96551418 |
| 31 | MP0002405_respiratory_system_inflammati | 1.93643538 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.90003437 |
| 33 | MP0004510_myositis | 1.89145466 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.89062147 |
| 35 | MP0004947_skin_inflammation | 1.81863424 |
| 36 | MP0002419_abnormal_innate_immunity | 1.81180968 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.80477596 |
| 38 | MP0002006_tumorigenesis | 1.76540107 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.60690271 |
| 40 | * MP0001845_abnormal_inflammatory_respons | 1.46850871 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.46726580 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.46726580 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.40525286 |
| 44 | MP0001853_heart_inflammation | 1.36699084 |
| 45 | MP0002933_joint_inflammation | 1.36502737 |
| 46 | MP0004381_abnormal_hair_follicle | 1.27966549 |
| 47 | MP0008569_lethality_at_weaning | 1.24205847 |
| 48 | MP0005310_abnormal_salivary_gland | 1.23504966 |
| 49 | MP0002132_abnormal_respiratory_system | 1.17425890 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.13841042 |
| 51 | MP0003787_abnormal_imprinting | 1.13792321 |
| 52 | MP0008874_decreased_physiological_sensi | 1.11577594 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.11471761 |
| 54 | MP0001879_abnormal_lymphatic_vessel | 1.11463322 |
| 55 | MP0003045_fibrosis | 1.08809864 |
| 56 | MP0006082_CNS_inflammation | 0.97466774 |
| 57 | MP0000569_abnormal_digit_pigmentation | 0.95768735 |
| 58 | MP0008260_abnormal_autophagy | 0.95606818 |
| 59 | * MP0009764_decreased_sensitivity_to | 0.92037904 |
| 60 | MP0001851_eye_inflammation | 0.91652957 |
| 61 | MP0002009_preneoplasia | 0.91223205 |
| 62 | MP0003172_abnormal_lysosome_physiology | 0.86572102 |
| 63 | MP0002019_abnormal_tumor_incidence | 0.85711347 |
| 64 | MP0002693_abnormal_pancreas_physiology | 0.85575218 |
| 65 | MP0003724_increased_susceptibility_to | 0.85370296 |
| 66 | MP0004484_altered_response_of | 0.84405341 |
| 67 | MP0004130_abnormal_muscle_cell | 0.83588372 |
| 68 | MP0004883_abnormal_blood_vessel | 0.83464138 |
| 69 | MP0004859_abnormal_synaptic_plasticity | 0.81358953 |
| 70 | MP0010368_abnormal_lymphatic_system | 0.80656361 |
| 71 | MP0003091_abnormal_cell_migration | 0.78569744 |
| 72 | MP0005451_abnormal_body_composition | 0.78134593 |
| 73 | * MP0008469_abnormal_protein_level | 0.76986236 |
| 74 | MP0003828_pulmonary_edema | 0.76917205 |
| 75 | MP0002163_abnormal_gland_morphology | 0.76873246 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.76540156 |
| 77 | MP0001533_abnormal_skeleton_physiology | 0.75444222 |
| 78 | MP0002928_abnormal_bile_duct | 0.75438031 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.73988534 |
| 80 | MP0002909_abnormal_adrenal_gland | 0.71266334 |
| 81 | MP0008004_abnormal_stomach_pH | 0.70586206 |
| 82 | MP0000490_abnormal_crypts_of | 0.70140852 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.67158588 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.67106749 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.66282713 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.65479086 |
| 87 | MP0001501_abnormal_sleep_pattern | 0.65128651 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 0.62703080 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 0.62378360 |
| 90 | MP0010630_abnormal_cardiac_muscle | 0.61511484 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.60912111 |
| 92 | MP0001663_abnormal_digestive_system | 0.60196682 |
| 93 | MP0000249_abnormal_blood_vessel | 0.60001220 |
| 94 | MP0005535_abnormal_body_temperature | 0.57966533 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.57935365 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.57703294 |
| 97 | MP0000858_altered_metastatic_potential | 0.57076249 |
| 98 | MP0003075_altered_response_to | 0.56644729 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.55857357 |
| 100 | MP0005166_decreased_susceptibility_to | 0.54716040 |
| 101 | MP0005390_skeleton_phenotype | 0.54491520 |
| 102 | MP0002822_catalepsy | 0.53808517 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.53689043 |
| 104 | MP0003448_altered_tumor_morphology | 0.52946378 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.52324442 |
| 106 | MP0001784_abnormal_fluid_regulation | 0.52277683 |
| 107 | MP0002083_premature_death | 0.50874655 |
| 108 | MP0001765_abnormal_ion_homeostasis | 0.50002487 |
| 109 | MP0003943_abnormal_hepatobiliary_system | 0.49794768 |
| 110 | MP0003690_abnormal_glial_cell | 0.49328455 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.48386706 |
| 112 | MP0009763_increased_sensitivity_to | 0.48085257 |
| 113 | MP0003279_aneurysm | 0.46874228 |
| 114 | MP0005023_abnormal_wound_healing | 0.46068547 |
| 115 | MP0000003_abnormal_adipose_tissue | 0.45769948 |
| 116 | MP0003633_abnormal_nervous_system | 0.44442766 |
| 117 | MP0005409_darkened_coat_color | 0.43745086 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.43741928 |
| 119 | MP0005621_abnormal_cell_physiology | 0.43157598 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.42282755 |
| 121 | MP0006054_spinal_hemorrhage | 0.41657717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.14971907 |
| 2 | Panhypogammaglobulinemia (HP:0003139) | 5.16298240 |
| 3 | T lymphocytopenia (HP:0005403) | 5.00794275 |
| 4 | Recurrent bronchitis (HP:0002837) | 4.96643430 |
| 5 | Recurrent viral infections (HP:0004429) | 4.92030486 |
| 6 | Verrucae (HP:0200043) | 4.81950678 |
| 7 | Papilloma (HP:0012740) | 4.81950678 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.72615407 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.67447339 |
| 10 | Cellulitis (HP:0100658) | 4.59311470 |
| 11 | Abnormality of the fingertips (HP:0001211) | 4.43784597 |
| 12 | B lymphocytopenia (HP:0010976) | 4.38230670 |
| 13 | Abnormality of B cell number (HP:0010975) | 4.38230670 |
| 14 | Chronic otitis media (HP:0000389) | 4.36035596 |
| 15 | IgM deficiency (HP:0002850) | 4.21226724 |
| 16 | Colitis (HP:0002583) | 4.19428705 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.16219451 |
| 18 | Inflammation of the large intestine (HP:0002037) | 4.07033260 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 4.04863011 |
| 20 | Thyroiditis (HP:0100646) | 3.90747983 |
| 21 | Meningitis (HP:0001287) | 3.84517404 |
| 22 | Gastrointestinal stroma tumor (HP:0100723) | 3.80166133 |
| 23 | Abnormality of T cells (HP:0002843) | 3.76265741 |
| 24 | Orchitis (HP:0100796) | 3.73125693 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.71048510 |
| 26 | Optic neuritis (HP:0100653) | 3.71048510 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.63043938 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.51376748 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.51376748 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.51025160 |
| 31 | Recurrent sinusitis (HP:0011108) | 3.35030158 |
| 32 | Lymphopenia (HP:0001888) | 3.34905257 |
| 33 | Chronic sinusitis (HP:0011109) | 3.32140697 |
| 34 | Severe combined immunodeficiency (HP:0004430) | 3.26639917 |
| 35 | Nasal polyposis (HP:0100582) | 3.24466289 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.23077561 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 3.18863112 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.18557284 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.15657196 |
| 40 | Petechiae (HP:0000967) | 3.13395912 |
| 41 | Pustule (HP:0200039) | 3.05495787 |
| 42 | Combined immunodeficiency (HP:0005387) | 3.05142011 |
| 43 | Emphysema (HP:0002097) | 2.97946601 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.88180057 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83200828 |
| 46 | Gingival bleeding (HP:0000225) | 2.82020250 |
| 47 | Eczematoid dermatitis (HP:0000976) | 2.77963904 |
| 48 | Bronchitis (HP:0012387) | 2.75000478 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.73632950 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.70627440 |
| 51 | Vasculitis (HP:0002633) | 2.68924447 |
| 52 | IgG deficiency (HP:0004315) | 2.68436842 |
| 53 | Vertebral arch anomaly (HP:0008438) | 2.67661337 |
| 54 | Hypochromic anemia (HP:0001931) | 2.63581419 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.62461920 |
| 56 | Purpura (HP:0000979) | 2.61944336 |
| 57 | Eosinophilia (HP:0001880) | 2.61264893 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.59208327 |
| 59 | Sepsis (HP:0100806) | 2.56168441 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.55658280 |
| 61 | Osteomyelitis (HP:0002754) | 2.55558267 |
| 62 | Increased IgM level (HP:0003496) | 2.55010939 |
| 63 | Recurrent otitis media (HP:0000403) | 2.54753742 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.53198806 |
| 65 | Increased IgE level (HP:0003212) | 2.51335639 |
| 66 | Recurrent skin infections (HP:0001581) | 2.49917910 |
| 67 | Hypoplasia of the thymus (HP:0000778) | 2.49866579 |
| 68 | Menorrhagia (HP:0000132) | 2.48932682 |
| 69 | Pulmonary embolism (HP:0002204) | 2.48397375 |
| 70 | Macroorchidism (HP:0000053) | 2.47474708 |
| 71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.45311892 |
| 72 | Urticaria (HP:0001025) | 2.43135901 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.37442155 |
| 74 | Stomatitis (HP:0010280) | 2.36988231 |
| 75 | Basal cell carcinoma (HP:0002671) | 2.36665342 |
| 76 | IgA deficiency (HP:0002720) | 2.35473957 |
| 77 | Restrictive lung disease (HP:0002091) | 2.34411715 |
| 78 | Acute hepatic failure (HP:0006554) | 2.31110164 |
| 79 | Increased mean platelet volume (HP:0011877) | 2.28148992 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27592218 |
| 81 | Granulocytopenia (HP:0001913) | 2.27544187 |
| 82 | Gingivitis (HP:0000230) | 2.26296932 |
| 83 | Chronic diarrhea (HP:0002028) | 2.25931184 |
| 84 | Episodic fever (HP:0001954) | 2.25779590 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.24857764 |
| 86 | Hypochromic microcytic anemia (HP:0004840) | 2.22793837 |
| 87 | Fatigue (HP:0012378) | 2.22280913 |
| 88 | Chest pain (HP:0100749) | 2.21320668 |
| 89 | Papilledema (HP:0001085) | 2.17888794 |
| 90 | Hyperacusis (HP:0010780) | 2.15881176 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 2.15578195 |
| 92 | Abnormality of binocular vision (HP:0011514) | 2.15511644 |
| 93 | Diplopia (HP:0000651) | 2.15511644 |
| 94 | Thrombocytosis (HP:0001894) | 2.10974764 |
| 95 | Leukocytosis (HP:0001974) | 2.09964350 |
| 96 | Myositis (HP:0100614) | 2.08167686 |
| 97 | Lymphoma (HP:0002665) | 2.07884824 |
| 98 | Epistaxis (HP:0000421) | 2.07204929 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 2.06845428 |
| 100 | Hematochezia (HP:0002573) | 2.06033774 |
| 101 | Obstructive lung disease (HP:0006536) | 2.04859319 |
| 102 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04859319 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.04337066 |
| 104 | Abnormality of the pleura (HP:0002103) | 2.00801729 |
| 105 | Microcytic anemia (HP:0001935) | 2.00128966 |
| 106 | Slow saccadic eye movements (HP:0000514) | 1.99367999 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97883899 |
| 108 | Stomach cancer (HP:0012126) | 1.97461619 |
| 109 | Mitral stenosis (HP:0001718) | 1.94635024 |
| 110 | Anorexia (HP:0002039) | 1.93970670 |
| 111 | Cerebral aneurysm (HP:0004944) | 1.92193974 |
| 112 | Encephalitis (HP:0002383) | 1.84821604 |
| 113 | Hemiplegia (HP:0002301) | 1.84591238 |
| 114 | Skin ulcer (HP:0200042) | 1.82167401 |
| 115 | Viral hepatitis (HP:0006562) | 1.80207137 |
| 116 | Long eyelashes (HP:0000527) | 1.79252840 |
| 117 | Increased density of long bones (HP:0006392) | 1.76854749 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.76449869 |
| 119 | Small epiphyses (HP:0010585) | 1.75418947 |
| 120 | Hemoptysis (HP:0002105) | 1.75363626 |
| 121 | Recurrent lower respiratory tract infections (HP:0002783) | 1.74715185 |
| 122 | Acute lymphatic leukemia (HP:0006721) | 1.73901029 |
| 123 | Abnormality of the intervertebral disk (HP:0005108) | 1.73787749 |
| 124 | Recurrent pneumonia (HP:0006532) | 1.73323684 |
| 125 | Pulmonary infiltrates (HP:0002113) | 1.69773221 |
| 126 | Heterotopia (HP:0002282) | 1.67701272 |
| 127 | Skin rash (HP:0000988) | 1.67382509 |
| 128 | Impaired platelet aggregation (HP:0003540) | 1.65267695 |
| 129 | Abnormal platelet function (HP:0011869) | 1.65267695 |
| 130 | Ulnar bowing (HP:0003031) | 1.59773704 |
| 131 | Arterial thrombosis (HP:0004420) | 1.59211291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.69417014 |
| 2 | MAP3K10 | 3.60862306 |
| 3 | PRPF4B | 2.96171303 |
| 4 | GRK6 | 2.84107806 |
| 5 | SIK2 | 2.71385530 |
| 6 | EEF2K | 2.65899938 |
| 7 | TIE1 | 2.47974229 |
| 8 | MAP3K13 | 2.25507704 |
| 9 | STK10 | 2.23007405 |
| 10 | TXK | 2.12431841 |
| 11 | ZAP70 | 2.10632421 |
| 12 | JAK3 | 2.05259232 |
| 13 | ITK | 2.00349726 |
| 14 | TYK2 | 1.96501795 |
| 15 | BTK | 1.91234884 |
| 16 | SYK | 1.87485432 |
| 17 | FGFR4 | 1.75629968 |
| 18 | FES | 1.71675328 |
| 19 | JAK1 | 1.68878696 |
| 20 | RIPK4 | 1.64190915 |
| 21 | ERN1 | 1.63823763 |
| 22 | PKN2 | 1.60630887 |
| 23 | FGFR3 | 1.56618642 |
| 24 | HCK | 1.54293268 |
| 25 | CAMKK2 | 1.53348944 |
| 26 | TRIB3 | 1.53157086 |
| 27 | MAP3K7 | 1.51714242 |
| 28 | CSF1R | 1.50559913 |
| 29 | PRKCH | 1.50149396 |
| 30 | CDK12 | 1.48556306 |
| 31 | MARK3 | 1.45498014 |
| 32 | LRRK2 | 1.44587209 |
| 33 | IKBKE | 1.42759556 |
| 34 | LCK | 1.41867259 |
| 35 | MAP3K14 | 1.40864392 |
| 36 | CSK | 1.34192072 |
| 37 | MAP3K11 | 1.31269155 |
| 38 | TNK2 | 1.28332315 |
| 39 | PRKD2 | 1.26087847 |
| 40 | CLK1 | 1.24794970 |
| 41 | BLK | 1.23548388 |
| 42 | TGFBR2 | 1.21525409 |
| 43 | MAP2K3 | 1.21437572 |
| 44 | MARK2 | 1.18611174 |
| 45 | TEC | 1.17712801 |
| 46 | KIT | 1.17606980 |
| 47 | SMG1 | 1.17573406 |
| 48 | BRD4 | 1.17356986 |
| 49 | NLK | 1.12749821 |
| 50 | HIPK2 | 1.06291125 |
| 51 | EPHB1 | 1.03706938 |
| 52 | PRKCQ | 0.96293179 |
| 53 | DAPK2 | 0.96158860 |
| 54 | TBK1 | 0.94171568 |
| 55 | TTN | 0.93360392 |
| 56 | PTK2B | 0.91864490 |
| 57 | CAMK1G | 0.89852745 |
| 58 | MAPK12 | 0.87998843 |
| 59 | SGK3 | 0.87233457 |
| 60 | PDK1 | 0.84966277 |
| 61 | FGFR2 | 0.84226489 |
| 62 | JAK2 | 0.84216527 |
| 63 | ALK | 0.82931516 |
| 64 | LYN | 0.81381825 |
| 65 | MAP3K1 | 0.81283360 |
| 66 | IRAK4 | 0.78608621 |
| 67 | PIM1 | 0.75071376 |
| 68 | IRAK1 | 0.74143885 |
| 69 | TAOK1 | 0.71695074 |
| 70 | MAPK7 | 0.71327724 |
| 71 | TYRO3 | 0.68827377 |
| 72 | SIK1 | 0.68679250 |
| 73 | PTK6 | 0.68111683 |
| 74 | IKBKB | 0.66412978 |
| 75 | CDK4 | 0.66180256 |
| 76 | SIK3 | 0.65436743 |
| 77 | BMPR2 | 0.65193679 |
| 78 | BMX | 0.63685230 |
| 79 | IRAK2 | 0.63504073 |
| 80 | NEK2 | 0.62808222 |
| 81 | RPS6KL1 | 0.62147067 |
| 82 | RPS6KC1 | 0.62147067 |
| 83 | PRKD1 | 0.61705071 |
| 84 | FGR | 0.61696011 |
| 85 | MAP2K2 | 0.61613865 |
| 86 | RIPK1 | 0.61249139 |
| 87 | FLT3 | 0.61093013 |
| 88 | WNK1 | 0.61067971 |
| 89 | PASK | 0.60798604 |
| 90 | MAPK4 | 0.60712795 |
| 91 | STK4 | 0.58658511 |
| 92 | STK11 | 0.58046671 |
| 93 | MAP3K3 | 0.56192110 |
| 94 | PDGFRB | 0.55404888 |
| 95 | CAMK4 | 0.53201058 |
| 96 | CAMK1D | 0.50452501 |
| 97 | CDC42BPA | 0.48883906 |
| 98 | SGK2 | 0.48807325 |
| 99 | MATK | 0.48368168 |
| 100 | FYN | 0.47833729 |
| 101 | RET | 0.47752138 |
| 102 | KDR | 0.47000005 |
| 103 | CHUK | 0.46993508 |
| 104 | CDK19 | 0.46963192 |
| 105 | CDK9 | 0.46693322 |
| 106 | DMPK | 0.46383719 |
| 107 | MAPK11 | 0.45680951 |
| 108 | TAOK2 | 0.45609654 |
| 109 | TESK2 | 0.45500612 |
| 110 | RPS6KA2 | 0.42224746 |
| 111 | KSR2 | 0.40095870 |
| 112 | NTRK2 | 0.39857838 |
| 113 | STK38 | 0.39779923 |
| 114 | PDPK1 | 0.39151889 |
| 115 | CAMK1 | 0.39098233 |
| 116 | GRK5 | 0.39074954 |
| 117 | TLK1 | 0.36424497 |
| 118 | MELK | 0.36258216 |
| 119 | MAP3K9 | 0.35943135 |
| 120 | ABL1 | 0.35941623 |
| 121 | TAOK3 | 0.35940541 |
| 122 | CDK6 | 0.35038385 |
| 123 | RPS6KA6 | 0.34821443 |
| 124 | MAP2K6 | 0.33750201 |
| 125 | TRPM7 | 0.33717455 |
| 126 | CSNK1A1L | 0.29570356 |
| 127 | CAMKK1 | 0.26559376 |
| 128 | DYRK1B | 0.26416192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.04624919 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.57924926 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.65807333 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.58903175 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.40238445 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.34089756 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.07297214 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03423132 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97294751 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.96684103 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93074754 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.87053494 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85576321 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.84816430 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82194131 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73761812 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.66611718 |
| 18 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.66128688 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63874020 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.63552202 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.56751933 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48248470 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48043429 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45945244 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39066727 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35065117 |
| 27 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.30886259 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30082403 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29572785 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17356225 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15648021 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11427386 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10863527 |
| 34 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10367101 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.09718651 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08791830 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05918859 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05696606 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05173399 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.04449602 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03830270 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01126115 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99497581 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97305668 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 0.97025432 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.96628984 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96524569 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96011958 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95373713 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.92812277 |
| 51 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91638195 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91586591 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90068834 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.89392141 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88924317 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88892152 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88027100 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.87316502 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86317491 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.86249152 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.86239710 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86096087 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85873537 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.85805257 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85477889 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.85066086 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83128294 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82624951 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.82411350 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80960692 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79688291 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79108060 |
| 73 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77970939 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.76001079 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75798181 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75447729 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74990021 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.74989473 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73875329 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.73072675 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.72555458 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.72023063 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71684689 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70959431 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70423764 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69049915 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68292555 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.67796521 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66355311 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66169165 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65561960 |
| 92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64936806 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64813869 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.64267240 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63973978 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62993589 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62679911 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61668544 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60789899 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60078576 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58650239 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.56862344 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.56519867 |
| 104 | Circadian entrainment_Homo sapiens_hsa04713 | 0.56346756 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56168614 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.56040967 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56023923 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54918959 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54667049 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54094392 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53917863 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52791420 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52639709 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51263693 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51012619 |
| 116 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49355379 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49334172 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49287208 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49178456 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48955356 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48885896 |
| 122 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.48855046 |
| 123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47788168 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47544909 |

